Distribution of twenty-four hour urinary taurine excretion and association with ischemic heart disease mortality in 24 populations of 16 countries: results from the WHO-CARDIAC study
In the head-to-head STEP 8 trial, semaglutide 2.4 mg produced 15.8% weight loss compared with 6.4% for liraglutide 3.0 mg over the same 68-week period
Phase 3 trials are ongoing under the NCT registry (the TRIUMPH series, plus dedicated cardiovascular and kidney outcome trials NCT06383390, NCT05929066, NCT05931367, and NCT05882045)
Glutathione may support maternal health, help manage oxidative stress, enhance detoxification processes, and potentially improve milk quality
doi: 10.1177/1932296815626723
Across the three trials, rates of hypoglycemic events were low with oral semaglutide 14 mg, empagliflozin 25 mg, sitagliptin 100 mg and liraglutide 1.8 mg